Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy

Experimental Neurology

Volumn 223, Issue 2, 2010, Pages 529-536

  Bhaskaran, Muthu D ^a,b   Smith, Bret N ^a,b  

^a Tulane University   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Anandamide; Endocannabinoid; Mossy fiber sprouting; Seizure; Vanilloid; VR1

Indexed keywords

ANANDAMIDE; BICUCULLINE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CAPSAICIN; CAPSAZEPINE; ENDOCANNABINOID; GLUTAMIC ACID; PILOCARPINE; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DENTATE GYRUS; DISEASE MODEL; DRUG DESIGN; EXCITATORY POSTSYNAPTIC POTENTIAL; GRANULE CELL; IN VITRO STUDY; MALE; MOUSE; NERVE CELL INHIBITION; NERVE CELL STIMULATION; NERVE SPROUTING; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR UPREGULATION; SYNAPTIC TRANSMISSION; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY; WESTERN BLOTTING;

ANIMALS; ANTICONVULSANTS; ARACHIDONIC ACIDS; CAPSAICIN; DENTATE GYRUS; DISEASE MODELS, ANIMAL; DRUG DESIGN; ENDOCANNABINOIDS; EPILEPSY, TEMPORAL LOBE; EXCITATORY POSTSYNAPTIC POTENTIALS; MALE; MICE; MICE, INBRED STRAINS; MOSSY FIBERS, HIPPOCAMPAL; MUSCARINIC AGONISTS; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; PILOCARPINE; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1; SENSORY SYSTEM AGENTS; SYNAPTIC TRANSMISSION; TRPV CATION CHANNELS;

EID: 77952552716     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.01.021     Document Type: Article

References (60)

1. Al-Hayani A., Wease K.N., Ross R.A., Pertwee R.G., Davies S.N. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 2001, 41:1000-1005.
2. Alger B.E., Pitler T.A. Retrograde signaling at GABAA-receptor synapses in the mammalian CNS. Trends Neurosci. 1995, 18:333-340.
3. Babb T.L., Kupfer W.R., Pretorius J.K., Crandall P.H., Levesque M.F. Synaptic reorganization by mossy fibers in human epileptic fascia dentata. Neuroscience 1991, 42:351-363.
4. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985, 14:375-403.
5. Ben-Ari Y., Tremblay E., Riche D., Ghilini G., Naquet R. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 1981, 6:1361-1391.
6. Benninger F., Freund T.F., Hajos N. Control of excitatory synaptic transmission by capsaicin is unaltered in TRPV1 vanilloid receptor knockout mice. Neurochem. Int. 2008, 52:89-94.
7. Bhaskaran M.D., Smith B.N. Cannabinoid and vanilloid interactions in the modified dentate gyrus of a pilocapine-induced status epilepticus mouse model of temporal lobe epilepsy. Epilepsia 2007, 48(S6):118.
8. Borges K., Gearing M., McDermott D.L., Smith A.B., Almonte A.G., Wainer B.H., Dingledine R. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp. Neurol. 2003, 182:21-34.
9. Braakman H.M.H., van Oostenbrugge R.J., van Kranen-Mastenbroek V.H.J.M., de Krom M.C.T.F.M. Rimonabant induces partial seizures in a patient with a history of generalized epilepsy. Epilepsia 2009, 50:2171.
10. Buckmaster P.S., Dudek F.E. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J Comp. Neurol. 1997, 385:385-404.
11. Caterina M.J., Rosen T.A., Tominaga M., Brake A.J., Julius D. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 1999, 398:436-441.
12. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
13. Cavalheiro E.A., Santos N.F., Priel M.R. The pilocarpine model of epilepsy in mice. Epilepsia 1996, 37:1015-1019.
14. Cristino L., de Petrocellis L., Pryce G., Baker D., Guglielmotti V., Di Marzo V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 2006, 139:1405-1415.
15. de Lanerolle N.C., Kim J.H., Robbins R.J., Spencer D.D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 1989, 495:387-395.
16. Derbenev A.V., Monroe M.J., Glatzer N.R., Smith B.N. Vanilloid-mediated heterosynaptic facilitation of inhibitory synaptic input to neurons of the rat dorsal motor nucleus of the vagus. J. Neurosci. 2006, 26:9666-9672.
17. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
18. Dudek F.E., Spitz M. Hypothetical mechanisms for the cellular and neurophysiologic basis of secondary epileptogenesis: proposed role of synaptic reorganization. J. Clin. Neurophysiol. 1997, 14:90-101.
19. Franck J.E., Pokorny J., Kunkel D.D., Schwartzkroin P.A. Physiologic and morphologic characteristics of granule cell circuitry in human epileptic hippocampus. Epilepsia 1995, 36:543-558.
20. Hajos N., Freund T.F. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology 2002, 43:503-510.
21. Houser C.R., Miyashiro J.E., Swartz B.E., Walsh G.O., Rich J.R., Delgado-Escueta A.V. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J. Neurosci. 1990, 10:267-282.
22. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Petros T.J., Krey J.F., Chu C.J., Miller J.D., Davies S.N., Geppetti P., Walker J.M., Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8400-8405.
23. Isokawa M., Alger B.E. Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell. J. Physiol. 2005, 567:1001-1010.
24. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 1999, 19:4544-4558.
25. Katona I., Sperlagh B., Magloczky Z., Santha E., Kofalvi A., Czirjak S., Mackie K., Vizi E.S., Freund T.F. GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience 2000, 100:797-804.
26. Kauer J.A., Gibson H.E. Hot flash: TRPV channels in the brain. Trends Neurosci. 2009, 32:215-224.
27. Kofalvi A., Oliveira C.R., Cunha R.A. Lack of evidence for functional TRPV1 vanilloid receptors in rat hippocampal nerve terminals. Neurosci. Lett. 2006, 403:151-156.
28. Kofalvi A., Pereira M.F., Rebola N., Rodrigues R.J., Oliveira C.R., Cunha R.A. Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus. Br. J. Pharmacol. 2007, 151:551-563.
29. Magloczky Z., Wittner L., Borhegyi Z., Halasz P., Vajda J., Czirjak S., Freund T.F. Changes in the distribution and connectivity of interneurons in the epileptic human dentate gyrus. Neuroscience 2000, 96:7-25.
30. Marinelli S., Vaughan C.W., Christie M.J., Connor M. Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J. Physiol. 2002, 543:531-540.
31. Marinelli S., Di Marzo V., Berretta N., Matias I., Maccarrone M., Bernardi G., Mercuri N.B. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J. Neurosci. 2003, 23:3136-3144.
32. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., van der Stelt M., Lopez-Rodriguez M.L., Casanova E., Schutz G., Zieglgansberger W., Di Marzo V., Behl C., Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003, 302:84-88.
33. Mathern G.W., Babb T.L., Pretorius J.K., Leite J.P. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J. Neurosci. 1995, 15:3990-4004.
34. 2+ of NMDA responses in spinal cord neurones. Nature 1984, 309:261-263.
35. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3655-3660.
36. Molnár P., Nadler J.V. Mossy fiber-granule cell synapses in the normal and epileptic rat dentate gyrus studied with minimal laser photostimulation. J. Neurophysiol. 1999, 82:1883-1894.
37. Patrylo P.R., Dudek F.E. Physiological unmasking of new glutamatergic pathways in the dentate gyrus of hippocampal slices from kainate-induced epileptic rats. J. Neurophysiol. 1998, 79:418-429.
38. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizures. Electrorencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
39. Roberts J.C., Davis J.B., Benham C.D. [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res. 2004, 995:176-183.
40. Shibley H., Smith B.N. Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice. Epilepsy Res. 2002, 49:109-120.
41. Sloviter R.S., Sollas A.L., Barbaro N.M., Laxer K.D. Calcium-binding protein (calbindin-D28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J. Comp. Neurol. 1991, 308:381-396.
42. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 2000, 129:227-230.
43. Smith B.N., Dudek F.E. Enhanced population responses in the basolateral amygdala of kainate-treated, epileptic rats in vitro. Neurosci. Lett. 1997, 222:1-4.
44. Smith B.N., Dudek F.E. Short- and long-term changes in CA1 network excitability after kainate treatment in rats. J. Neurophysiol. 2001, 85:1-9.
45. Smith B.N., Dudek F.E. Network interactions mediated by new excitatory connections between CA1 pyramidal cells in rats with kainate-induced epilepsy. J. Neurophysiol. 2002, 87:1655-1658.
46. Starowicz K., Cristino L., Di Marzo V. TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications. Curr. Pharm. Des. 2008, 14:42-54.
47. Stein A.T., Ufret-Vincenty C.A., Hua L., Santana L.F., Gordon S.E. Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J. Gen. Physiol. 2006, 128:509-522.
48. Sutula T., Cascino G., Cavazos J., Parada I., Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol. 1989, 26:321-330.
49. Szallasi A., Blumberg P.M. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev. 1999, 51:159-212.
50. Tauck D.L., Nadler J.V. Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J. Neurosci. 1985, 5:1016-1022.
51. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21:531-543.
52. Toth A., Boczan J., Kedei N., Lizanecz E., Bagi Z., Papp Z., Edes I., Csiba L., Blumberg P.M. Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res. Mol. Brain Res. 2005, 135:162-168.
53. Van Der Stelt M., Di Marzo V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur. J. Biochem. 2004, 271:1827-1834.
54. Wallace M.J., Martin B.R., DeLorenzo R.J. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur. J. Pharmacol. 2002, 452:295-301.
55. Wallace M.J., Blair R.E., Falenski K.W., Martin B.R., DeLorenzo R.J. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther. 2003, 307:129-137.
56. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
57. Winokur R.S., Kubal T., Liu D., Davis S.F., Smith B.N. Recurrent excitation in the dentate gyrus of a murine model of temporal lobe epilepsy. Epilepsy Res. 2004, 58:93-105.
58. Wuarin J.P., Dudek F.E. Electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated epileptic rats. J. Neurosci. 1996, 16:4438-4448.
59. Wuarin J.P., Dudek F.E. Excitatory synaptic input to granule cells increases with time after kainate treatment. J. Neurophysiol. 2001, 85:1067-1077.
60. Zhu Z.Q., Armstrong D.L., Hamilton W.J., Grossman R.G. Disproportionate loss of CA4 parvalbumin-immunoreactive interneurons in patients with Ammon's horn sclerosis. J. Neuropathol. Exp. Neurol. 1997, 56:988-998.